SciELO - Scientific Electronic Library Online

 
vol.40 issue1Hyperbaric oxygen therapy as an adjunctive treatment for COVID-19-associated mucormycosis: a report of two cases author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Peruana de Medicina Experimental y Salud Publica

Print version ISSN 1726-4634

Abstract

ZUMAETA-SAAVEDRA, Enrique; CHIARA-CHILET, Christian; MAQUERA-AFARAY, Julio  and  LUNA-VILCHEZ, Medalit. Recurrent laryngeal papillomatosis with pulmonary involvement: case report. Rev. perú. med. exp. salud publica [online]. 2023, vol.40, n.1, pp.111-114.  Epub Mar 24, 2023. ISSN 1726-4634.  http://dx.doi.org/10.17843/rpmesp.2023.401.12169.

Recurrent respiratory papillomatosis is a neoplastic disease caused by the human papillomavirus and characterized by the growth of exophytic proliferative lesions affecting the mucosa of the respiratory tract. This condition has a bimodal age distribution; the juvenile form affects those under 20 years of age, is more aggressive and presents multiple papillomatous lesions and high frequency of recurrence, compared to the adult form. Pulmonary involvement is rare and challenging to treat. We present the case of a 13-year-old male with a history of laryngeal papillomatosis since the age of two years. The patient showed respiratory distress and multiple stenosing nodules in the larynx and trachea, as well as several pulmonary cysts identified on chest CT. The patient underwent excision of the papillomatous lesions and tracheostomy. Then, the patient received a single dose of intravenous bevacizumab 400 mg and respiratory therapies with favorable evolution, without recurrences during follow-up.

Keywords : Human Papilloma Virus; Respiratory Papillomatosis; Microsurgery.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )